LCT-3d Induces Oxidative Stress-Mediated Apoptosis by Upregulating Death Receptor 5 in Gastric Cancer Cells.

LCT-3d Induces Oxidative Stress-Mediated Apoptosis by Upregulating Death Receptor 5 in Gastric Cancer Cells.
复制标题

DOI:
10.3389/fonc.2021.658608
复制
发表时间:
2021
影响因子:
4.7
通讯作者:
Jin CY
Jin CY
中科院分区:
医学3区
文献类型:
--
作者:
Wang M;Wu X;Yu L;Hu ZY;Li X;Meng X;Lv CT;Kim GY;Choi YH;Wang Z;Xu HW;Jin CY

文献摘要

参考文献

被引文献

相似文献

胃癌是一个全球性的健康问题。在这项研究中,我们研究了一种新的吲哚衍生物,称为LCT-3D,通过四甲基偶氮唑盐比色法研究了其抑制胃癌细胞生长的作用。Western blotting结果表明,LCT-3D可调控线粒体相关蛋白和切割Caspase3/9,从而诱导细胞凋亡。观察LCT-3D对MGC803细胞死亡受体5(DR5)表达的上调作用。敲除DR5基因可部分逆转LCT-3D诱导的线粒体凋亡。LCT-3D可使MGC803细胞内的ROS水平升高,并可被ROS抑制剂N-乙酰半胱氨酸(NAC)阻断。结果表明,ROS升高可上调DR5的表达,通过线粒体途径诱导细胞凋亡。尽管核因子红系2相关因子2(Nrf2)通路在保护胃癌细胞免受ROS损伤中发挥了重要作用,但它不能逆转LCT-3D诱导的细胞凋亡。综上所述,我们的研究表明,LCT-3D通过DR5介导的线粒体凋亡途径诱导胃癌细胞凋亡。LCT-3D可能是一种新的先导化合物,用于开发胃癌的抗癌活性。
Gastric cancer is a global health problem. In this study, we investigate the role of a novel Indole derivative, named LCT-3d, in inhibiting the growth of gastric cancer cells by MTT assay. The Western blotting results showed that LCT-3d modulated the mitochondrial-related proteins and Cleaved-Caspases 3/9, to induce cell apoptosis. The up-regulation of Death receptor 5 (DR5) in MGC803 cells was observed with LCT-3d treatment. Knockdown of DR5 on MGC803 cells partially reversed the LCT-3d-induced mitochondrial apoptosis. The level of Reactive Oxygen Species (ROS) in MGC803 cells was increased with LCT-3d treatment and could be blocked with the pretreatment of the ROS inhibitor N-Acetylcysteine (NAC). The results demonstrate that the elevating ROS can up-regulate the expression of DR5, resulting in apoptosis via mitochondrial pathway. Although the nuclear factor erythroid-2 related factor 2 (Nrf2) pathway served an important role in protecting gastric cancer cells against the injury of ROS, it can’t reverse LCT-3d-induced cell apoptosis. Taken together, our study showed that LCT-3d induced apoptosis via DR5-mediated mitochondrial apoptotic pathway in gastric cancer cells. LCT-3d could be a novel lead compound for development of anti-cancer activity in gastric cancer.
DOI: 10.3389/fonc.2020.574861
发表时间: 2020
影响因子: 4.7
作者:
Gao HL;Gupta P;Cui Q;Ashar YV;Wu ZX;Zeng L;Lei ZN;Teng QX;Ashby CR Jr;Guan Y;Chen ZS
通讯作者: Chen ZS
DOI: 10.1016/j.bmcl.2020.127763
发表时间: 2021-01-08
影响因子: 2.7
作者:
Sadhu, M. Naveen;Sivanandhan, Dhanalakshmi;Rajagopal, Sridharan
通讯作者: Rajagopal, Sridharan
DOI: 10.3390/cancers12061702
发表时间: 2020-06-01
期刊: CANCERS
影响因子: 5.2
作者:
Wang, Yi-Yue;Lee, Kyung-Tae;Choi, Jung-Hye
通讯作者: Choi, Jung-Hye
DOI: 10.1248/bpb.b18-00157
发表时间: 2018-09-01
影响因子: 2
作者:
Jin,Cheng-Yun;Molagoda,Ilandarage Menu Neelaka;Choi,Yung Hyun
通讯作者: Choi,Yung Hyun
DOI: 10.3389/fcell.2020.607275
发表时间: 2020
影响因子: 5.5
作者:
Lei ZN;Teng QX;Zhang W;Fan YF;Wang JQ;Cai CY;Lu KW;Yang DH;Wurpel JND;Chen ZS
通讯作者: Chen ZS